Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Murugan Selvam
Observed name:
Selvam Murugan
Institution:
Roswell Park Comprehensive Cancer Center
Observed institution:
Roswell Park Comprehensive Cancer Center
ORCID:
0000-0002-5939-2251
Observed ORCID:
0000-0002-5939-2251
OpenAlex ID:
A5102993149
FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia
2024
·
Pamela J. Sung
, Murugan Selvam
, et al.
·
Leukemia
·
23
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy
2023
·
Daria Frank
, Pradeep Kumar Patnana
, et al.
·
Blood
·
17
A novel BCR::ABL1 I502T mutation associated with acquired asciminib resistance in CML
2026
·
Murugan Selvam
, Rahul Kumar Thakur
, et al.
·
Leukemia Research
POSTER: CML-1215: A Novel BCR::ABL1 I502 T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia
2026
·
Murugan Selvam
, Rahul Kumar Thakur
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-1215: A Novel BCR::ABL1 I502 T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia
2026
·
Murugan Selvam
, Rahul Kumar Thakur
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Abstract 7107: Dual FLT3/BRAF inhibitor PHI3 overcomes RAS-driven resistance in FLT3-mutant AML
2026
·
Shikhar Sharma
, Anna Skwarska
, et al.
·
Cancer Research
Geographic distribution and equity in access to gastrointestinal cancer clinical trials in the United States.
2026
·
Rahul Kumar Thakur
, Barun Ray
, et al.
·
Journal of Clinical Oncology
Combined FLT3 and EZH1/2 inhibition reduces LSCs and promotes myeloid differentiation in PDX models of AML
2025
·
Murugan Selvam
, Marianna Giorgi
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
8
Citation count:
40
H-index:
2
I10-index:
2
Year
Topic
Type